Response to "inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993 - The perspective of NIH clinical trialists"

Otis W. Brawley

doi:10.1016/0197-2456(95)00131-X

Response to "inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993 - The perspective of NIH clinical trialists"

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	293-295
Number of pages	3
Journal	Controlled clinical trials
Volume	16
Issue number	5
DOIs	https://doi.org/10.1016/0197-2456(95)00131-X
State	Published - Oct 1995
Externally published	Yes

ASJC Scopus subject areas

Pharmacology

Access to Document

10.1016/0197-2456(95)00131-X

Cite this

@article{bdf392fddeb3424c89290c6bd5d0ea0b,

title = "Response to {"}inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993 - The perspective of NIH clinical trialists{"}",

author = "Brawley, {Otis W.}",

year = "1995",

month = oct,

doi = "10.1016/0197-2456(95)00131-X",

language = "English (US)",

volume = "16",

pages = "293--295",

journal = "Controlled Clinical Trials",

issn = "0197-2456",

publisher = "Elsevier BV",

number = "5",

}

TY - JOUR

T1 - Response to "inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993 - The perspective of NIH clinical trialists"

AU - Brawley, Otis W.

PY - 1995/10

Y1 - 1995/10

UR - http://www.scopus.com/inward/record.url?scp=0028856922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028856922&partnerID=8YFLogxK

U2 - 10.1016/0197-2456(95)00131-X

DO - 10.1016/0197-2456(95)00131-X

M3 - Article

AN - SCOPUS:0028856922

VL - 16

SP - 293

EP - 295

JO - Controlled Clinical Trials

JF - Controlled Clinical Trials

SN - 0197-2456

IS - 5

ER -